Manchester Capital Management LLC Bristol Myers Squibb CO Transaction History

Manchester Capital Management LLC

$802 Million
Q1 2024

A detailed history of Manchester Capital Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Manchester Capital Management LLC holds 22,546 shares of BMY stock, worth $936,335. This represents 0.15% of its overall portfolio holdings.

Number of Shares

22,546

Previous 22,148 1.8%

Holding current value

$936,335

Previous $1.14 Million 7.57%

% of portfolio

0.15%

Previous 0.15%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$47.98 - $54.4 $19,096 - $21,651	398 Added 1.8%	22,546 $1.22 Million
Q4 2023 Feb 08, 2024	SELL	$48.48 - $57.85 $127,647 - $152,319	-2,633 Reduced 10.63%	22,148 $1.14 Million
Q3 2023 Nov 09, 2023	SELL	$57.89 - $64.73 $87,529 - $97,871	-1,512 Reduced 5.75%	24,781 $1.44 Million
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $3,758 - $4,173	-59 Reduced 0.22%	26,293 $1.68 Million
Q1 2023 May 09, 2023	BUY	$65.71 - $74.53 $52,370 - $59,400	797 Added 3.12%	26,352 $1.83 Million

Q4 2022 Feb 09, 2023	SELL	$68.48 - $81.09 $112,718 - $133,474	-1,646 Reduced 6.05%	25,555 $1.84 Million
Q3 2022 Nov 08, 2022	BUY	$0.13 - $76.84 $145 - $85,983	1,119 Added 4.29%	27,201 $1.93 Million
Q2 2022 Aug 10, 2022	BUY	$72.62 - $79.98 $133,185 - $146,683	1,834 Added 7.56%	26,082 $2.01 Million
Q1 2022 May 09, 2022	SELL	$61.48 - $73.72 $77,464 - $92,887	-1,260 Reduced 4.94%	24,248 $1.77 Million
Q4 2021 Feb 10, 2022	SELL	$53.63 - $62.52 $187,490 - $218,569	-3,496 Reduced 12.05%	25,508 $1.59 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $90,056 - $105,489	1,522 Added 5.54%	29,004 $1.72 Million
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $49,014 - $55,127	826 Added 3.1%	27,482 $1.74 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $25,925 - $29,378	449 Added 1.71%	26,656 $1.65 Million
Q3 2020 Oct 27, 2020	SELL	$57.43 - $63.64 $190,495 - $211,093	-3,317 Reduced 11.23%	26,207 $1.58 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $75,168 - $109,236	1,620 Added 5.81%	29,524 $1.65 Million
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $511,980 - $667,832	10,404 Added 59.45%	27,904 $1.79 Million
Q3 2019 Nov 04, 2019	SELL	$42.77 - $50.71 $3,635 - $4,310	-85 Reduced 0.48%	17,500 $887,000
Q2 2019 Aug 05, 2019	SELL	$44.62 - $49.34 $30,743 - $33,995	-689 Reduced 3.77%	17,585 $797,000
Q1 2019 May 08, 2019	BUY	$45.12 - $53.8 $364,524 - $434,650	8,079 Added 79.24%	18,274 $872,000
Q4 2018 Feb 04, 2019	BUY	$48.76 - $63.23 $17,699 - $22,952	363 Added 3.69%	10,195 $564,000
Q3 2018 Nov 01, 2018	SELL	$55.19 - $62.25 $20,033 - $22,596	-363 Reduced 3.56%	9,832 $610,000
Q2 2018 Aug 08, 2018	BUY	$50.53 - $62.98 $116,825 - $145,609	2,312 Added 29.33%	10,195 $564,000
Q1 2018 May 07, 2018	BUY	$59.92 - $68.98 $11,564 - $13,313	193 Added 2.51%	7,883 $499,000
Q4 2017 Feb 08, 2018	BUY	$59.94 - $65.35 $3,116 - $3,398	52 Added 0.68%	7,690 $471,000
Q3 2017 Nov 09, 2017	BUY	$55.23 - $63.74 $421,846 - $486,846	7,638	7,638 $487,000

Others Institutions Holding BMY

# of Institutions

2,554

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $88.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manchester Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manchester Capital Management LLC with notifications on news.

Account

Manchester Capital Management LLC Bristol Myers Squibb CO Transaction History